Non-Biological Complex Drugs - The Science and the Regulatory Landscape (Paperback, Softcover reprint of the original 1st ed. 2015)

The rise of bio- and nano-technology in the last decades has led to the emergence of a new and unique type of medicine known as non-biological complex drugs (NBCDs). This book illustrates the challenges associated with NBCD development, as well as the complexity of assessing the effects of manufacturing changes on innovator and follow-on batches of NBCDs. It also touches upon proven marketing authorization requirements for biosimilars that could be effective in evaluating follow-on NBCDs, including a demonstration of control over the manufacturing process and a need for detailed physico-chemical characterization and (pre)clinical tests. This book is meant to be used for years to come as a standard reference work for the development of NBCDs. Moreover, this book aims to stimulate discussions and further our thinking to ensure that decisions regarding the approval of complex drugs are made with relevant scientific data on the table.

General

Imprint:	Springer International Publishing AG
Country of origin:	Switzerland
Series:	AAPS Advances in the Pharmaceutical Sciences Series, 20
Release date:	October 2016
First published:	2015
Editors:	Daan J.A. Crommelin • Jon S B De Vlieger
Dimensions:	235 x 155 x 21mm (L x W x T)
Format:	Paperback
Pages:	390
Edition:	Softcover reprint of the original 1st ed. 2015
ISBN-13:	978-3-319-35851-2
Categories:	Books > Professional & Technical > Industrial chemistry & manufacturing technologies > Industrial chemistry > Pharmaceutical technology
LSN:	3-319-35851-0
Barcode:	9783319358512

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!